• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON BD NANO PEN NEEDLES 2ND GENERATION; NEEDLE, HYPODERMIC, SINGLE LUMEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON BD NANO PEN NEEDLES 2ND GENERATION; NEEDLE, HYPODERMIC, SINGLE LUMEN Back to Search Results
Model Number 0.23MM X 4MM (32G X 5/32")
Device Problems Fail-Safe Problem (2936); Material Twisted/Bent (2981)
Patient Problems Hemorrhage/Bleeding (1888); Needle Stick/Puncture (2462)
Event Date 02/27/2023
Event Type  malfunction  
Event Description
Using the bd brand nano 2nd gen pen needles for insulin shot administered to my spouse, upon placing the protective plastic cap back onto the needle after use, i did not noticed that the needle had become slightly bent to the side and when placing the plastic protector cap back onto the nano needle to safely dispose of, the needle pierced through the plastic protector cap which i had not noticed resulting in my index finger becoming pricked and bleeding.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NANO PEN NEEDLES 2ND GENERATION
Type of Device
NEEDLE, HYPODERMIC, SINGLE LUMEN
Manufacturer (Section D)
BECTON DICKINSON
MDR Report Key16468286
MDR Text Key310680918
Report NumberMW5115373
Device Sequence Number1
Product Code FMI
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 02/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model Number0.23MM X 4MM (32G X 5/32")
Device Lot Number2180163
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/01/2023
Patient Sequence Number1
Patient SexFemale
-
-